Evidence map›Paper›PMID 24800999›Full record

ArticlePloS one2014

Who has used internal company documents for biomedical and public health research and where did they find them?

L Susan Wieland, Lainie Rutkow, S Swaroop Vedula, Christopher N Kaufmann, Lori M Rosman, Claire Twose, Nirosha Mahendraratnam, Kay Dickersin

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

L Susan WielandCenter for Evidence-Based Medicine, Brown University, Providence, Rhode Island, United States of America.
Lainie RutkowJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
S Swaroop VedulaJohns Hopkins University, Baltimore, Maryland, United States of America.
Christopher N KaufmannJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Lori M RosmanWilliam H. Welch Medical Library, Johns Hopkins University, Baltimore, Maryland, United States of America.
Claire TwoseWilliam H. Welch Medical Library, Johns Hopkins University, Baltimore, Maryland, United States of America.
Nirosha MahendraratnamJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Kay DickersinJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the sources of internal company documents used in public health and healthcare research.

methodsWe searched PubMed and Embase for articles using internal company documents to address a research question about a health-related topic. Our primary interest was where authors obtained internal company documents for their research. We also extracted information on type of company, type of research question, type of internal documents, and funding source.

resultsOur searches identified 9,305 citations of which 357 were eligible. Scanning of reference lists and consultation with colleagues identified 4 additional articles, resulting in 361 included articles. Most articles examined internal tobacco company documents (325/361; 90%). Articles using documents from pharmaceutical companies (20/361; 6%) were the next most common. Tobacco articles used documents from repositories; pharmaceutical documents were from a range of sources. Most included articles relied upon internal company documents obtained through litigation (350/361; 97%). The research questions posed were primarily about company strategies to promote or position the company and its products (326/361; 90%). Most articles (346/361; 96%) used information from miscellaneous documents such as memos or letters, or from unspecified types of documents. When explicit information about study funding was provided (290/361 articles), the most common source was the US-based National Cancer Institute. We developed an alternative and more sensitive search targeted at identifying additional research articles using internal pharmaceutical company documents, but the search retrieved an impractical number of citations for review.

conclusionsInternal company documents provide an excellent source of information on health topics (e.g., corporate behavior, study data) exemplified by articles based on tobacco industry documents. Pharmaceutical and other industry documents appear to have been less used for research, indicating a need for funding for this type of research and well-indexed and curated repositories to provide researchers with ready access to the documents.

Indexed as

IndustryBiomedical ResearchData MiningPublic HealthPubMedRecords

Identifiers

PMID24800999
PMCPMC4011692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.